Data from the literature usually present sporadic cases of peripheral myxomatous embolism with very good results of surgical treatment of ischemia, as well as the removal of a heart tumor. [ 31 , 32 ] ...

Of the 360 patients in the study population, 38 had recurrent venous thromboembolism (10.6 percent) (deep-vein thrombosis in 24 and pulmonary embolism in 14). Of these 38 patients, 27 were men and ...

Veterinary Clinics of North America: Small Animal Practice. 2004 vol 34, 5: 1209-1226. doi: 10.1016/J.CVSM.2004.05.002. 3 Keene, Bruce W et al. “ACVIM consensus guidelines for the diagnosis and ...

MENLO PARK, Calif., June 16, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, the leading innovator in the treatment of venous thromboembolic disease, today announced that its AVENTUS Thrombectomy System has ...

Distal peripheral microembolism is caused by embolization of atherosclerotic debris into small arteries and arterioles. The recent advances in endovascular technique have been met with a gradual ...

For pt.I see ibid., vol.43, no.6, p.572-80 (1996). A theoretical and numerical study of the acoustic field intensity within a curved flow conduit having (1) diameter similar to the wavelength of the ...

Four hundred and ninety-nine surgically excised valves were examined for pathological evidence of myxomatous degeneration. Thirty-six valves (7%) had myxomatous degeneration as a major pathological ...

Penumbra’s chief medical officer James Benenati said: “This is an important milestone that underscores Penumbra’s commitment to transforming care for patients with pulmonary embolism. “The trial ...

The coils offer extended lengths of up to 70cm. Credit: Penumbra/PR Newswire. Penumbra has introduced Ruby XL System, the detachable embolisation coil, which has also received clearance from the US ...

June 5, 2025—Penumbra, Inc. announced the FDA clearance and launch of the Ruby XL system, part of the company’s Ruby portfolio of peripheral embolization products. According to Penumbra, the Ruby XL, ...